CAS: 6272-38-4; 2-(Benzyloxy)Phenol

上下游产品

CAS号100-44-7 氯化苄 | CAS号120-80-9 邻苯二酚 | CAS号100-39-0 溴化苄 | CAS号190661-29-1 2-苄氧基苯硼酸 | CAS号725268-38-2 (2S,3R)-2,3-bis... | CAS号69617-72-7 (3S,4S,5R,1'S)-... | CAS号122204-66-4 methyl 2,6-dibr... | CAS号90-02-8 水杨醛 | CAS号5896-17-3 2-苄氧基苯甲醛 | CAS号4579-60-6 N-(对羟基苯乙基)-N-(3... | CAS号46049-49-4 (S)-2,3-二氢-1,4-... | CAS号17455-25-3 二苯并-30-冠-10 | CAS号23116-94-1 1,5-双(2-羟基苯氧基)-... | CAS号289471-92-7 2-苄氧基-4-碘苯酚 | CAS号29938-06-5 2-phenylmethoxy... | CAS号98572-00-0 (S)-2-羟甲基-1,4-苯并二恶烷 | CAS号74495-69-5 愈创木酚-D3 | CAS号6346-05-0 3-苄氧基-4-甲氧基苯甲醛 | CAS号33130-23-3 2-(2-methoxyeth...

2-苄氧基苯硼酸置于c38H34Cl2Np3Pd,氧气,三乙胺体系中,用 氯仿 作为反应溶剂,化学反应 24.0H,以77%的收率获得产物2-苯甲氧基苯酚
参考文献:[pd(L)Cl2]-催化芳基硼酸选择性羟基化反应生成苯酚
标题:[pd(L)Cl2]-催化芳基硼酸选择性羟基化反应生成苯酚
摘要:钯配合物 [pd(L)Cl2] (1) 已通过 Pd(Cod)Cl2(cod = 1,5-环辛二烯)与 L [n,N'-双(二苯基膦酰基)-2-(二苯基膦酰基)乙胺].配体l和配合物1已通过元素分析,质谱和1H/31P NMR光谱表征.在 O2 存在下,1置于298 K 的低介电常数溶剂中选择性催化各种芳基硼酸羟基化为相应的苯酚衍生物,尽管在具有高介电常数的溶剂中,相同的反应导致两种苯酚的形成和偶联产物,即联芳基.已经解决了从芳基硼酸与 1 形成选择性苯酚的机制方面.
DOI:10.1002/ejic.201100240

专利信息

专利号:US-RE31624-E
优先权日:1979-11-26
标 题 :Method of treating inflammation
摘要:A method of treating inflammation and inhibiting prostaglandin synthesis employing substituted 2-(arylmethoxy)phenol compounds.

专利号:WO-2013088056-A1
优先权日:2011-12-12
标 题:High‑yield synthesis of p-(benzyloxy)calix[6, 7, 8]arenes

专利号:US-4244956-A
优先权日:1979-11-26
标题 :Method of treating inflammation
发明人：DEWHIRST FLOYD E
权利人:FORSYTH DENTAL INFIRMARY
摘要:A method of treating inflammation and inhibiting prostaglandin synthesis employing substituted 2-(arylmethoxy)phenol compounds.

专利号:WO-2006006496-A1
优先权日:2004-07-08
标题:Process for production of azulene derivatives and intermediates for the synthesis of the same

专利号:EP-2791097-A1
优先权日:2011-12-12
标 题:High yield synthesis of p-(benzyloxy)calix[6,7,8]arenes

专利号:US-7989438-B2
优先权日:2007-07-17
标题 :Therapeutic compounds
发明人：CONTE IMMACOLATA; HABERMANN JOERG; MACKAY ANGELA; NARJES FRANK; RICO FERREIRA MARIA DEL ROSARIO; STANSFIELD IAN
权利人:ANGELETTI P IST RICHERCHE BIO
摘要:A class of macrocyclic compounds of formula (I), wherein R 7 , A, Ar, B, D, F, M, Q 1 , Q 2 , W, X, Y and Z are defined herein, that are useful as inhibitors of viral proteases, particularly the hepatitis C virus (HCV) NS3 protease, are provided. Also provided are processes for the synthesis and use of such macrocyclic compounds for treating or preventing HCV infection.